Neuroonkologie
Translationale Neuroonkologie

Programme

• 13:30 – 13:40 7 Min. 3 Min.

  • Abstractvortrag

  TTFields and the drug-repurposing approach CUSP9v3 lead to a predominantly synergistic anti-glioblastoma activity in vitro

  • Georg Karpel-Massler (Ulm)
• 13:40 – 13:50 7 Min. 3 Min.

  • Abstractvortrag

  FTY720 (Fingolimod) has stronger an antiproliferative effect on human Glioblastoma cells in combination with Temozolomide

  • Malgorzata Kolodziej (Gießen)
• 13:50 – 14:00 7 Min. 3 Min.

  • Abstractvortrag

  EphrinB2 in bone endothelial cells controls metastatic seeding to individual spinal segments

  • Maximilian Geißler (Frankfurt am Main)
• 14:00 – 14:10 7 Min. 3 Min.

  • Abstractvortrag

  Pharmaceutical Screening in a ex vivo tumor slice model for vestibular schwannoma

  • Maria Breun (Würzburg)
• 14:10 – 14:20 7 Min. 3 Min.

  • Abstractvortrag

  Effect of Tumor Treating Fields in combination with Irradiation on the survival of human glioblastoma cells

  • Hanna Goett (Gießen)
• 14:20 – 14:30 7 Min. 3 Min.

  • Abstractvortrag

  Tumormicroenvironment in Vestibular schwannoma with and without NF2

  • Maria Breun (Würzburg)